Cullinan Therapeutics, Inc.

NasdaqGS:CGEM Stock Report

Market Cap: US$1.0b

Cullinan Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:CGEM Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
26 Dec 23SellUS$39,473Nadim AhmedIndividual4,272US$9.24
21 Dec 23SellUS$9,733Jennifer MichaelsonIndividual1,145US$8.50
21 Dec 23SellUS$16,320Jeffrey TrigilioIndividual1,920US$8.50
21 Dec 23SellUS$11,900Jacquelyn SumerIndividual1,400US$8.50
21 Dec 23SellUS$15,810Jeffrey JonesIndividual1,860US$8.50
18 Dec 23SellUS$3,272Jeffrey TrigilioIndividual398US$8.22
18 Dec 23SellUS$2,384Jacquelyn SumerIndividual290US$8.22
18 Dec 23SellUS$3,173Jeffrey JonesIndividual386US$8.22
18 Dec 23SellUS$1,956Jennifer MichaelsonIndividual238US$8.22
12 Dec 23SellUS$8,341Jennifer MichaelsonIndividual1,068US$7.81
12 Dec 23SellUS$15,042Jeffrey TrigilioIndividual1,926US$7.81

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of CGEM?
Owner TypeNumber of SharesOwnership Percentage
Private Companies402,3060.604%
Individual Insiders2,613,4543.92%
Hedge Funds16,679,18825%
Institutions46,907,33170.4%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 35.7%.

Top Shareholders

Top 25 shareholders own 90.52% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
13.2%
BioImpact Capital LLC
7,648,268US$132.3m0%20.84%
9.92%
BVF Partners L.P.
5,750,683US$99.5m79.9%2.46%
6.12%
BlackRock, Inc.
3,550,207US$61.4m46.2%no data
5.66%
Deerfield Management Company, L.P. Series C
3,280,237US$56.7m188%0.87%
4.95%
The Vanguard Group, Inc.
2,871,375US$49.7m61.8%no data
4.18%
Franklin Resources, Inc.
2,421,945US$41.9m-8.82%0.01%
3.85%
Adage Capital Management, L.P.
2,232,829US$38.6m135%0.07%
3.53%
CHI Advisors LLC
2,049,172US$35.5m-29.9%13.04%
3.35%
Citadel Advisors LLC
1,943,139US$33.6m75.2%0.03%
3.35%
State Street Global Advisors, Inc.
1,941,188US$33.6m36.2%no data
3.06%
Morana Jovan-Embiricos
1,775,155US$30.7m0%no data
2.98%
AllianceBernstein L.P.
1,728,545US$29.9m5,110%0.01%
2.69%
Avidity Partners Management, L.P.
1,559,826US$27.0m0%1.08%
2.66%
Paradigm Biocapital Advisors LP
1,542,805US$26.7m14.5%0.94%
2.38%
VR Adviser, LLC
1,379,965US$23.9m0%0.98%
2.27%
Holocene Advisors, LP
1,316,005US$22.8m0%0.09%
2.11%
Nextech Invest Ltd.
1,221,145US$21.1m0%3.12%
2.04%
Marshall Wace LLP
1,184,037US$20.5m2,420%0.03%
1.98%
OrbiMed Advisors LLC
1,147,655US$19.9m122%0.28%
1.94%
Cormorant Asset Management, LP
1,125,000US$19.5m0%1.01%
1.82%
Artal Group S.A.
1,057,949US$18.3m0%0.44%
1.82%
RTW Investments, LP
1,052,630US$18.2m0%0.28%
1.68%
Geode Capital Management, LLC
976,486US$16.9m44.2%no data
1.59%
Tang Capital Management, LLC
921,138US$15.9m61.3%1.43%
1.39%
Morgan Stanley, Investment Banking and Brokerage Investments
803,239US$13.9m-28.5%no data